XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 160 filers reported holding XENON PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $707 | -8.4% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $772 | +9.0% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $708 | -9.3% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $781 | -99.9% | 20,000 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $721,000 | +90.7% | 20,000 | +61.3% | 0.00% | +100.0% |
| Q2 2022 | $378,000 | +1.3% | 12,400 | 0.0% | 0.00% | 0.0% |
| Q1 2022 | $373,000 | +3.9% | 12,400 | +9.7% | 0.00% | 0.0% |
| Q4 2021 | $359,000 | +121.6% | 11,300 | +2.7% | 0.00% | – |
| Q3 2021 | $162,000 | -17.3% | 11,000 | 0.0% | 0.00% | -100.0% |
| Q2 2021 | $196,000 | +3.2% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $190,000 | +21.0% | 11,000 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $157,000 | – | 11,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ghost Tree Capital, LLC | 790,000 | $12,071,000 | 3.53% |
| GREAT POINT PARTNERS LLC | 700,000 | $10,696,000 | 2.49% |
| COMMODORE CAPITAL LP | 579,432 | $8,854,000 | 2.33% |
| ACUTA CAPITAL PARTNERS, LLC | 417,409 | $6,378,000 | 2.25% |
| DAFNA Capital Management LLC | 406,535 | $6,212,000 | 1.65% |
| Tri Locum Partners LP | 264,134 | $4,036,000 | 1.60% |
| Parkman Healthcare Partners LLC | 311,207 | $4,755,000 | 1.20% |
| Ghost Tree Capital, LLC | 250,000 | $3,820,000 | 1.12% |
| Nan Fung Group Holdings Ltd | 197,880 | $3,024,000 | 0.97% |
| BVF INC/IL | 1,571,778 | $24,017,000 | 0.94% |